WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8601 Infant (under 12 months) mortality rate: 642
GDP / capita (US$): 2'1101 Child (under 5 years) mortality rate: 1002

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 10'872  10'576  10'287  10'004  9'729  6'866  4'978  3'717 
Births 403  397  390  383  376  292  231  176 
Surviving infants 378  371  364  358  351  266  206  154 
Pop. less than 5 years 1'775  1'739  1'704  1'671  1'637  1'221  920  681 
Pop. less than 15 years 4'661  4'552  4'448  4'345  4'242  3'099  2'280  1'661 
Female 15-49 years 2'558  2'483  2'410  2'340  2'271  1'561  1'122  845 

Number of reported cases

(Click for retrospective incidence data for Benin)
Diphtheria
ChartChart
  127 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  89  55  786  637  288  4'244  18'635 
Mumps
ChartChart
 
Pertussis
ChartChart
  215  2'694 
Polio*
ChartChart
  81  155 
Rubella
ChartChart
  40  10  41 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  52  247 
Tetanus (total)**
ChartChart
  122  288  499 
Yellow fever
ChartChart
  10 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Benin)
Vaccine year result method % card seen                                                
BCG 2013  90  MICS   73  97  98  96  98  97  99*  74 
DTP1 2013  86  MICS   73  76  98  94  98  94  99* 
DTP3 2013  74  MICS   73  63  91  90  93  85  88  78 
DTP4         
IPV1          79  61 
HepB_BD         
HepB3 2013  74  MICS   73  63  91  90  93  85 
Hib3 2013  74  MICS   73  63  91  90  93  85 
JapEnc         
MCV1          63  85  87  87  72  85  73 
MCV2         
MenA         
PCV1          76  99*  90  98  99* 
PCV2          99*  96  92  94  99* 
PCV3 2013  67  MICS   73  63  91  90  93  36 
Pol3 2013  64  MICS   73  63  91  90  93  85  88  78 
Rota1         
RotaC         
RCV1         
TT2plus 2012  85  CES   89  64  77  69  69  82  81  46 
PAB         
VAD1         
YFV 2013  70  MICS   73  63  85  87  87  72 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Benin)
BCG
ChartChart
  96  96  96  95  96  92  92 
DTP1
ChartChart
  86  86  86  86  89  89  86 
DTP3
ChartChart
  82  82  78  77  80  78  74 
HepB3
ChartChart
  82  82  78  77  80 
HepB_BD
ChartChart
 
Hib3
ChartChart
  82  82  78  77  80 
IPV1
  62  31 
MCV1
ChartChart
  74  74  68  68  74  70  79 
MCV2
ChartChart
 
PCV3
ChartChart
  75  75  71  70  67 
Pol3
ChartChart
  78  78  74  73  80  78  74 
RCV1
 
RotaC
 
YFV
ChartChart
  78  77  70  70  69 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 77  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 4
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9 years, +6 months; No
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes From January 2018
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes CBAW
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2018  2014-2018  2014-2018  2014-2018  2009-2013  2009-2013   
Nº of districts with microplans that include activities to raise immunization coverage number 77  77  77  56  77  77 

System performance

Total Nº districts in country number 77  77  77  77  77  77  77 
Nº districts with DTP3 coverage >=80% number 71  70  56  65  73  72  70 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  91  73  84  95  94  91 
Nº districts with measles (MCV1) coverage >=95% number 57  39  29  15  36  19  37 
% of districts with MCV1 coverage >=95% From 0 to 100% 74  51  38  19  47  25  48 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No  Yes  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  NA  Yes  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 69  33  33  76  17  35 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.